Zhang, Yifei
Comenzo, Raymond L.
Article History
Accepted: 20 September 2021
First Online: 30 May 2022
Compliance With Ethical Standards
:
: Yifei Zhang declares that he has no conflict of interest. Raymond L. Comenzo has a patent issued (WO2016187546A1) for anti-cd38 antibodies for treatment of light-chain amyloidosis and other cd38-positive hematological malignancies
: This article does not contain any studies with human or animal subjects performed by any of the authors.